Molecular characterization of beta-thalassaemia in 174 Greek patients with thalassaemia major. 1990

C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
First Department of Pediatrics, University of Athens, Greece.

The mutations producing beta-thalassaemia in 174 Greek patients with thalassaemia major were investigated by dot-blot hybridization of oligonucleotide probes to genomic DNA amplified by the polymerase chain reaction procedure, by direct sequencing of amplified DNA, and by gene mapping. beta-thalassaemia in Greeks was found to be very heterogeneous at the molecular level as 17 different mutations were observed: 86.6% of the beta-thalassaemic genes, however, could be identified with five probes: IVS-I-110 (G----A) (42.5%), codon 39 (C----T) (17%), IVS-I-1 (G----A) (13.2%), IVS-I-6 (T----C) (7.2%) and IVS-II-745 (C----G) (6.9%). Several mutations which had not previously been reported in the Greek population and which occurred at an incidence of 2% or lower were observed in this study. The information obtained will facilitate the prenatal diagnosis of beta-thalassaemia in Greece.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D015345 Oligonucleotide Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin. Oligodeoxyribonucleotide Probes,Oligonucleotide Probe,Oligoribonucleotide Probes,Probe, Oligonucleotide,Probes, Oligodeoxyribonucleotide,Probes, Oligonucleotide,Probes, Oligoribonucleotide

Related Publications

C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
May 1989, British journal of haematology,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
February 1988, Journal of clinical pathology,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
July 2012, Blood transfusion = Trasfusione del sangue,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
June 2005, Heart (British Cardiac Society),
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
January 2008, Scandinavian journal of clinical and laboratory investigation,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
November 1988, British journal of haematology,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
July 1993, Journal of clinical pathology,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
December 2006, Diabetic medicine : a journal of the British Diabetic Association,
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
July 2009, Acta physiologica (Oxford, England),
C Kattamis, and H Hu, and G Cheng, and A L Reese, and J M Gonzalez-Redondo, and A Kutlar, and F Kutlar, and T H Huisman
January 2000, Ultrastructural pathology,
Copied contents to your clipboard!